![Troy Seelye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Seelye
Geen lopende functies
Profiel
Troy Seelye worked as a Senior Manager-Network Infrastructure Engineering at Amgen, Inc. He then worked at Illumina, Inc. as the Head-Global IT Operations from 2014 to 2017.
From 2017 to 2020, he was the Chief Information Officer at Teradata Corp.
He also worked as the Chief Information Officer at Biora Therapeutics, Inc. Mr. Seelye completed his undergraduate degree at California Lutheran University.
Eerdere bekende functies van Troy Seelye
| Bedrijven | Functie | Einde |
|---|---|---|
| TERADATA CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-03-2020 |
| ILLUMINA, INC. | Corporate Officer/Principal | 01-01-2017 |
| AMGEN INC. | Corporate Officer/Principal | - |
| BIORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Troy Seelye
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
California Lutheran University
 California Lutheran University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teradata Corp.
 Teradata Corp. Packaged SoftwareTechnology Services Provides cloud analytics software solutions | Technology Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
